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Introduction: Iatrogenic arteriovenous fistula is a vascular condition that may result from coronary angiography.
Many case reports have described arteriovenous fistula occurrence after coronary angiography using the
transfemoral access route, but rarely as a complication of using the transradial approach. We report a rare case of a
patient with arteriovenous fistula following transradial artery coronary angiography.
Case presentation: A 62-year-old Caucasian man underwent emergent coronary angiography using the right radial
artery approach. One month after angiography, he discovered a turbulent sound near the access site. A right radial
arteriovenous fistula was found upon duplex ultrasound investigation. The patient was treated conservatively. At
1-year follow-up, the arteriovenous fistula was unchanged and the patient remained hemodynamically stable and
asymptomatic.
Conclusion: Iatrogenic arteriovenous fistula is a rare vascular complication of transradial artery coronary
angiography. The natural history of arteriovenous fistula is benign and is thought to resolve spontaneously;
therefore, a conservative approach, as opposed to surgical ligation, is recommended as the first-line treatment.Introduction
Two to five percent of patients presenting with an acute
coronary syndrome (ACS) experience major bleeding [1,2],
a clinical factor which has been established as an independ-
ent predictor of mortality [3,4]. As a substantial portion of
bleeding occurs at the femoral site during transfemoral cor-
onary angiography and/or angioplasty, the field of interven-
tional cardiology has turned its attention to accessing the
heart from the radial artery. This is a superficial and readily
compressible site that, in comparison to the transfemoral
approach, has been proven to reduce major bleeding and is
associated with reduction in mortality [5]. In addition, the
transradial artery (TRA) approach is associated with
increased comfort and decreased time to ambulation.
Vascular complications such as access site hematomas,
retroperitoneal hematomas, pseudoaneurysms, arterio-
venous fistula (AVF) and arterial dissection are related
more to femoral artery puncture sites than to radial ac-
cess sites. Although reported with a very rare incidence
in the medical literature [6], there are no publications* Correspondence: pdehghani@mac.com
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reproduction in any medium, provided the ordescribing non-surgical, conservative treatment of AVF
from the TRA approach. We report the first case of AVF
that was managed conservatively using this technique
and review the literature regarding the pathophysiology,
risk factors for, natural history of and potential manage-
ment strategies for AVF in the radial artery.Case presentation
A 62-year-old Caucasian man with a body mass index
(BMI) of 26kg/m2 and no classic risk factors for coron-
ary artery disease presented with an ACS requiring
emergent coronary angiography. After confirming dual
arterial supply of the palmar arch with a normal Allen’s
test, angioplasty of the proximal and mid-left anterior
descending artery was carried out using a 6-French,
23cm radial sheath (Cordis Corporation, Miami, FL,
USA) in the right radial artery. Bivalirudin, with an ini-
tial bolus of 0.75mg/kg followed by 1.75mg/kg/hour for
the duration of the procedure, was used for anticoagula-
tion. The radial artery sheath was removed immediately
after completion of percutaneous coronary intervention
(PCI), and hemostasis was achieved by application of an
adjustable plastic clamp on the radial artery. The clamp
was gradually released over 2 hours while the access siteral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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removed after satisfactory access site hemostasis was
achieved. After an uneventful hospital stay, the patient
was discharged on the appropriate medical therapy. One
month later he complained of a “swishing” sensation in
his right forearm. He did not complain of finger claudi-
cation or numbness. His physical examination confirmed
a palpable thrill at the right radial puncture site. An ultra-
sound (Figure 1) with color Doppler imaging showed an
AVF with turbulent, high-velocity flow at the site of com-
munication. There was no circulatory compromise to the
hand, and the Allen’s test remained normal.
The patient was sent to a vascular surgeon, who elected
to follow the patient conservatively. A repeat ultrasound
performed 1 year later showed exactly the same anatomy,
without any increase in the fistulous connection. At this
time, the patient continues to have no discomfort at the
access site.
Discussion
In comparison with transfemoral access, TRA coronary
angiography has repeatedly been shown to improve pa-
tient satisfaction [7,8], reduce resource use [8-10] and
lower risk of vascular complications [5,7]. In a recent
prospective registry of 455 patients undergoing TRA
coronary angiography, of whom only 15% underwent an
intervention, the most common access site complica-
tions were radial artery occlusions in 25%, pseudoaneur-
ysms in 0.6% and AVFs in 0.9%, and no major bleeding
was reported [11]. Although most of the medical com-
munity has come to interpret this registry’s unacceptably
high rates of radial artery occlusion with caution [12],
the remainder of the findings are consistent with other
published findings of low rates of vascular compromiseFigure 1 An ultrasound scan of the right radial artery revealed the ar
arrow) between the vein and the radial artery (ART).[5,7]. No specific mention was made of treatment strat-
egies for patients with AVF in the registry cohort. Even
more relevant to our case is the largest randomized trial
to compare radial and femoral access, the RIVAL study
[7], which included 7021 patients with ACS undergoing
intervention. Although the primary outcome, a compos-
ite of death, myocardial infarction, stroke or non–coron-
ary artery bypass graft–related bleeding at 30 days, was
not statistically significant between the radial and fem-
oral approaches, major vascular complications, defined
as large hematoma, pseudoaneurysm, AVF and ischemic
limb needing surgery, occurred in 1.4% of radial arms
compared to 3.8% of femoral arms (P < 0.001).
Acquired AVF caused by transfemoral coronary angi-
ography is not uncommon, owing to the frequency of
the groin as the site of percutaneous arterial and venous
access. However, AVF in the arm is very rare and has
been reported very infrequently [13-15]. In the RIVAL
study, 5 (0.14%) of the 3514 patients undergoing transfe-
moral PCI had AVF, whereas none of the 3507 patients
in the TRA arm were reported to have AVF. Regardless
of whether the upper or lower extremity is involved, the
pathophysiology of iatrogenic AVF is the same. During
access, needle deviation through a venous tributary can
lead to an unnoticed combined artery and vein puncture.
Most of the time the communication between the artery
and vein will seal spontaneously. However, when the
communication does not seal, an AVF may form.
The technique and experience of the operator, compres-
sion at the access site, management of hemostasis after
catheterization, closure devices used and nursing care
must be considered when evaluating the patient’s risk
of developing vascular complications post-angiography.
Potential ways to minimize the incidence of AVF includeteriovenous fistula seen as turbulent high velocity flow (orange
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the same artery is accessed, (3) using a sheath size that is
less than the arterial diameter and (4) using ultrasound-
guided needle placement to provide anatomic information
such as diameter, tortuosity and proximity of the radial ar-
tery to the vein. Reviewing the literature on the incidence
and risk factors of AVF caused by femoral angiography can
be instructive as well. In the largest series of its kind, Kelm
et al. found that significant predictors of AVF in this pa-
tient population were high heparin dosage, coumadin ther-
apy, puncture of the left groin, arterial hypertension and
female gender [16]. Interestingly, other than anticoagula-
tion with bivalirudin, our patient had none of these risk
factors and his artery was accessed after the first puncture.
What is the natural history of persistent AVF? If the
AVF is large enough, two potential hemodynamic conse-
quences may be seen. First, significant hemodynamic shift
can occur from the higher systemic vascular resistance in
the artery to the lower resistance in the venous circuit.
The ensuing increase in stroke volume from increased
venous return may potentiate high output failure. Second,
AVF in the lower extremity, in the setting of pre-existing
vascular disease, can lead to the potential worsening of is-
chemic symptoms. The experience derived from treating
AVF due to femoral artery catheterization suggests that
most cases can resolve spontaneously. In Kelm et al.’s de-
scription of the cohort of patients with transfemoral AVF,
one-third of the AVFs closed spontaneously within 1 year
[16]. In another report, 81% of patients’ AVFs resolved
spontaneously within 200 days after femoral angiography
[17]. Looking at the natural history of iatrogenic AVF in
high-risk hemodialysis patients can also be instructive.
Keeping in mind the different patient population as well
as the larger diameter of the brachial artery, the most re-
cent report, which described a cohort of 628 hemodialysis
patients with surgically caused AVFs with 8 years of fol-
low-up, 16% experienced one or more complications [18].
Hemorrhage, failure to mature and aneurysms were the
most common complications seen in the early, immediate
and late groups, respectively [18]. Limb ischemia and car-
diac insufficiency, the two complications with the most
dreaded hemodynamic sequelae, were seen in only 3.6% of
the entire cohort.
There are four potential therapeutic approaches for
patients with persistent iatrogenic AVF. First, surgical re-
pair, the approach taken for all the reported cases of ra-
dial AVF undergoing coronary angiography [13-15], has
been advocated as the intervention of choice. This is an
invasive option with its own reported rates of peri-
operative morbidity and mortality [17]. Surgical options
depend on the size and location of the AVF and include
partial resection, ligation, excision and repair. Second,
implantation of a covered stent, previously described in
the femoral artery [19-21], has inherent limitations in theradial artery, given the small size of the artery, the poten-
tial likelihood of restenosis and the unknown natural his-
tory. Third, ultrasound-guided compression, which has
been well-described in the population with AVF after use
of the trans-femoral approach, may be an option. There
have been no reports of ultrasound-guided compressions
in the radial artery, however, and the experience of fem-
oral complications suggests low rates of success [22,23].
Fourth, conservative therapy, the approach taken in our
patient, is a viable option, given the benign natural history
of AVF and the fact most seal spontaneously. This case
challenges the dogma that AVF caused by use of the TRA
approach needs to be addressed surgically, as was the case
in all the previous publications describing this complica-
tion [13-15]. It is our opinion that as long as radial AVF is
of no inconvenience to the patient, is not enlarging and
does not cause neurovascular compromise and/or cardiac
insufficiency, it should be treated conservatively without
any intervention.
Although many complications can arise with iatrogenic
AVF, there is enough evidence in the literature to suggest
that its natural history is benign and therefore can be
managed expectantly. Appropriate follow-up of stable
patients presenting with AVF post-TRA catheterization
includes clinical and ultrasound assessment.
Conclusion
Iatrogenic AVF is a rare vascular complication of trans-
radial coronary angiography that may be treated conser-
vatively without any interventions.
Patient’s perspective
I am a 62-year-old male Caucasian with little medical
knowledge or background. I am writing as my own per-
spective on conditions that led to development of a fis-
tula in my right wrist.
In late July 2010, usually while walking, I had been no-
ticing an unusual sensation in my upper arms and across
my chest. It was enough of an oddity to motivate me to
go to our family doctor. He prescribed a nitroglycerin
spray and blood work that I had done at a local lab.
A few days later, prior to having received any lab
results, I went to a kids’ camp to work as a volunteer
custodian. I couldn’t have been too worried about health
risks as I neglected to take the nitroglycerin spray with
me to the camp.
By the end of the first day of cutting grass at the camp
I felt unusually exhausted. Although I had no pain, my
daughter (a registered nurse), convinced me to go to the
nearby hospital at Fort Qu’Appelle to get checked out.
Blood samples were taken and indicated high enzyme
levels. The hospital staff advised me that I had had a
heart attack and I was sent by ambulance to the Regina
General Hospital.
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plasty procedure and inserted two stents. A few days later,
I was released from hospital. However, I soon noticed what
I called “my vibrating wrist” in my right wrist, in the area
that the angioplasty catheter had been inserted. I showed
this to Dr. Dehghani who said that I had a fistula, an unex-
pected, abnormal connection between a vein and artery.
I was sent for an ultrasound examination and to an
appointment with a vascular surgeon. I stated that the
fistula was not really bothering me. The surgeon recom-
mended that no further action be taken since risks of
the status quo were likely less than if I were to have vas-
cular surgery to try to correct the fistula.
Over the past 18 months since the angioplasty proced-
ure, my “vibrating wrist” has become gradually less no-
ticeable. The fistula has never bothered me and now, I
have mostly forgotten that it is still there.
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